Corvus Pharmaceuticals In...

NASDAQ: CRVS · Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT

Corvus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-62.29M -27.03M -41.31M -43.24M
Depreciation & Amortization
85K 151K 367K 460K
Stock-Based Compensation
3M 2.15M 2.69M 4.23M
Other Working Capital
-2.65M -3.71M 1.08M -827K
Other Non-Cash Items
35.43M 4.39M 9.81M 5.07M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.65M -3.59M 1.41M -3.24M
Operating Cash Flow
-25.42M -23.93M -27.02M -36.72M
Capital Expenditures
n/a -34K -269K -5K
Cash Acquisitions
5K n/a 22K -21.57K
Purchase of Investments
-70.12M -47.05M -66.19M -9.36M
Sales Maturities Of Investments
42.63M 62.62M 43.16M 30.92M
Other Investing Acitivies
n/a n/a n/a 21.57K
Investing Cash Flow
-27.48M 15.54M -23.28M 21.56M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
32.62M 12K n/a 1.22M
Financial Cash Flow
49.03M 7.86M n/a 62.16M
Net Cash Flow
-3.88M -539K -50.3M 47M
Free Cash Flow
-25.42M -23.97M -27.29M -36.72M